Sainz, L.; Riera, P.; Moya, P.; Bernal, S.; Casademont, J.; DÃaz-Torné, C.; Millán, A.M.; Park, H.S.; Lasa, A.; Corominas, H.
Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis. J. Pers. Med. 2023, 13, 61.
https://doi.org/10.3390/jpm13010061
AMA Style
Sainz L, Riera P, Moya P, Bernal S, Casademont J, DÃaz-Torné C, Millán AM, Park HS, Lasa A, Corominas H.
Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis. Journal of Personalized Medicine. 2023; 13(1):61.
https://doi.org/10.3390/jpm13010061
Chicago/Turabian Style
Sainz, Luis, Pau Riera, Patricia Moya, Sara Bernal, Jordi Casademont, Cesar DÃaz-Torné, Ana Milena Millán, Hye Sang Park, Adriana Lasa, and Héctor Corominas.
2023. "Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis" Journal of Personalized Medicine 13, no. 1: 61.
https://doi.org/10.3390/jpm13010061
APA Style
Sainz, L., Riera, P., Moya, P., Bernal, S., Casademont, J., DÃaz-Torné, C., Millán, A. M., Park, H. S., Lasa, A., & Corominas, H.
(2023). Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis. Journal of Personalized Medicine, 13(1), 61.
https://doi.org/10.3390/jpm13010061
